Clinical Trial Update: First-in-Human Trial of Single Ascending Dose, Multiple Ascending Dose and Malaria Challenge Model in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 first-in-human trial evaluating single ascending dose, multiple ascending dose, and a malaria challenge model in healthy participants has been completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2023-10-16